Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-03-29
1997-11-18
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544253, 544280, A61K 31505, C07D23970
Patent
active
056888007
ABSTRACT:
A novel pyrimidine derivative having an excellent antitumor activity, which is represented by the following general formula (I) or a pharmacologically acceptable salt thereof: ##STR1## wherein R.sup.1 represents a hydroxyl or amino group;
REFERENCES:
patent: 4997838 (1991-03-01), Akimoto
patent: 5028608 (1991-07-01), Taylor
patent: 5106974 (1992-04-01), Akimoto
Martin et al., Cancer Research, 46, 2189-2192 (1986).
Pazour, ASCO Abstracts, #C-856 in Proceeding, Am. Soc. Clin. Oncology, 3, 219 (1984).
Paull, Arzheim-Forsch/Drug Res., 34(II), 1984, pp. 1243-1246.
Drugs of the Future, 16, pp. 856-857 (1991).
Casper, Cancer, 72, 766 (1993).
Schnur et al., J. Med.Chem., 34, 914-918 (1991).
Estey, Cancer Treatment Reports, 70, 1105-1115 (1986).
Goodman & Gilman, The Pharmacological Bases of Therapeutics, 8th Edition, 1226-1227 (1990).
DeGraw, Drugs of the Future, 14, 849-851 (1989).
Haneda Toru
Kitoh Kyosuke
Kotake Yoshihiko
Nomura Hiroaki
Ueda Norihiro
Bernhardt Emily
Eisai Co. Ltd.
LandOfFree
Condensed pyrimidine derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Condensed pyrimidine derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Condensed pyrimidine derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1565870